by Truveta Staff | Apr 2, 2024 | Technology
A common misconception is that drugs and devices must gain explicit approval from the FDA for each specific use before healthcare providers can employ them. However, a practice known as off-label use challenges this notion, revealing a broader landscape of treatment...
by Truveta Staff | Mar 29, 2024 | Research, Technology
Prior to the new Medicare guidelines going into effect, Truveta Research and Zeke Emanuel, MD, PhD from the University of Pennsylvania, explored the first-time prescribing and dispensing of anti-obesity GLP-1 RA medications for US adults aged 60 to 69 with obesity or...
by Truveta Staff | Mar 18, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
by Truveta Staff | Mar 13, 2024 | News, Technology
Truveta has won the 2024 South by Southwest Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). TLM is a large-language, multi-modal AI model for transforming electronic health record (EHR) data into...
by Truveta Staff | Mar 12, 2024 | Technology
Stories from women whose endometriosis pain has been dismissed are devastatingly common. A typical woman in the United States will wait 10 years after her symptoms first appear to receive an endometriosis diagnosis. This delay is rooted in a pervasive lack of...
by Truveta Staff | Mar 11, 2024 | Technology
Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...